Press

Acarix is a Swedish MedTech company marketing the CADScor®System – the innovative, non-invasive device designed to support a reliable and cost-effective rule-out of significant coronary artery disease (CAD) at the very first stage of the diagnostic pathway.

We are committed to bringing about a change in the early warning and assessment of cardiac and vascular diseases. Our press releases can be found below. For product images, press kits and other inquiries, please contact us.